1. Making history. The high-level meeting on antimicrobial resistance Sept. 21 was just the fourth time the U.N. General Assembly had discussed a health issue — the others were HIV, noncommunicable diseases, and Ebola.
2. Building blocks. The countries pledged commitment to build action plans based on the “Global Action Plan on Antimicrobial Resistance,” developed in 2015 by the World Health Organization, the Food and Agriculture Organization of the United Nations and the World Organisation for Animal Health.
3. The plan. Each country will come up with a plan to monitor antibiotic use in healthcare and in agriculture, start reducing the drugs’ use and also begin developing new antibiotics, according to NPR coverage. They will present their plans to the U.N. General Assembly in 2018 for a progress assessment.
4. Reason for optimism. “I think this is the first realistic chance, in our lifetime, to turn this around,” Keiji Fukuda, MD, special representative for antimicrobial resistance to the director-general of WHO, told NPR. A similar U.N. declaration in 2001 on HIV helped the world make progress on that disease.
5. Potential weaknesses. The declaration did not set solid goals for antibiotic use reduction, and it is nonbinding, The New York Times reports.
More articles on antibiotic resistance:
Antibiotic resistance detected in cluster of gonorrhea infections
Poultry meat can spread MRSA to humans, study shows
13 drug giants pledge to curb antibiotic pollution at factories
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.